Mumbai (Maharashtra) [India], Aug 12 (ANI): Equity benchmark indices erased early losses but lay flat in the negative terrain at close on Wednesday with pharma stocks remaining under pressure.
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
Mumbai (Maharashtra) [India], July 31 (ANI): Equity benchmark indices closed marginally lower on Friday in line with Asian peers following a record contraction in economic data from the United States.
Mumbai (Maharashtra) [India], July 27 (ANI): Equity benchmark indices slipped during early hours on Monday mainly due to losses witnessed in pharma and banking stocks.
Mumbai (Maharashtra) [India], July 24 (ANI): Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with multi-year investigations by the Department of Justice's (DoJ's) Anti-trust Division and Civil Division into the
Mumbai (Maharashtra) [India], July 20 (ANI): Equity benchmark indices were up by nearly 1 per cent during early hours on Monday following handsome gains by private banks.
Mumbai (Maharashtra) [India], June 11 (ANI): Equity benchmark indices traded lower during early hours on Thursday as traders booked profit across counters, a day after the US Federal Reserve said that it sees interest rates near zero through 2022.
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
Mumbai (Maharashtra) [India], May 29 (ANI): Sun Pharmaceutical Industries said on Friday it has received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamostat Mesilate in Covid-19 patients.
Mumbai (Maharashtra) [India], April 3 (ANI): Equity benchmark indices slipped further on Friday as banks and financial stocks dragged with investors expecting a deterioration in their asset qualities due to disruption in economic activity from the coronavirus outbreak.
Mumbai (Maharashtra) [India], Feb 26 (ANI): Equity indices tracked their global peers and closed deep into the red on Wednesday as effects of coronavirus outbreak reverberated beyond China.